Aadi Bioscience: Funding, Investors & Team (Oct 2026)
Aadi Bioscience, Inc. is a biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi’s primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Aadi’s initial focus is the treatment of an ultra-rare cancer PEComa, also known as perivascular epithelioid cell tumor.
Aadi Bioscience has raised $173M across 2 funding rounds on record, the most recent an undisclosed round of $100M announced in Mar 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aadi Bioscience Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Aadi Bioscience Funding Rounds
Aadi Bioscience raised $72.5M in a Post-IPO Equity announced in Sep 2022.
2.5 years later, an undisclosed round of $100M was announced in Mar 2025.
Aadi Bioscience Founders and Leadership Team
Contact details for the Aadi Bioscience team: 1 of 1 has an email address on file.
Start 14-day free trial →Aadi Bioscience Funding Compared to Other Biotechnology Startups
Aadi Bioscience's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aadi Bioscience in Biotechnology and Pacific Palisades
Companies Similar to Aadi Bioscience
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Aadi Bioscience Funding FAQs
What does Aadi Bioscience do?
Aadi Bioscience, Inc. is a biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi’s primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Aadi’s initial focus is the treatment of an ultra-rare cancer PEComa, also known as perivascular epithelioid cell tumor.
How much funding has Aadi Bioscience raised?
Aadi Bioscience has raised $173M across 2 rounds on record. The most recent is an undisclosed round of $100M announced in Mar 2025.
When did Aadi Bioscience last raise funding?
Aadi Bioscience's most recent funding round on record is an undisclosed round of $100M, announced in Mar 2025.
Who founded Aadi Bioscience?
FundedIQ lists Neil Desai (Founder) at Aadi Bioscience.
Where is Aadi Bioscience headquartered?
Aadi Bioscience is based in Pacific Palisades, California, United States.
How many employees does Aadi Bioscience have?
Aadi Bioscience is in the 51-100 employee band.
How does Aadi Bioscience's funding compare to other Biotechnology startups?
Aadi Bioscience's latest round of $100M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Aadi Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aadi Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.